Our mission is to improve the quality of life through innovative biotechnology solutions.
We aim to build company value and shareholder wealth by utilising our capabilities to identify, in-license and develop innovative healthcare solutions.
- 06 Aug 2013: Company lodges prospectus with ASIC
- 31 Jul 2013: Notice of General Meeting
- 21 Jun 2013: Letter to Shareholders
- 15 May 2013: TELESSO TO ACQUIRE DERMATOLOGY COMPANY
- 27 Feb 2013: Half Yearly Report and Accounts
- 04 Feb 2013: Suspension Request
- 22 Jan 2013: Results of Meeting
- 21 Dec 2012: Notice of Annual General Meeting
- 17 Dec 2012: ! Suspension from official quotation